GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GN10284 structure
    GN10284Dioscin
    CAS: 19057-60-4
    Purity: >98.00%
  • GN10285 structure
    GN10285Theobromine
    CAS: 83-67-0
    Purity: >99.00%
  • GN10289 structure
    GN10289Trigonelline
    CAS: 535-83-1
    Purity: >99.50%

    Trigonelline, un alcaloïde de Trigonella foenum-graecum L ou de Leonurus artemisia, est un inhibiteur puissant et spécifique de Nrf2.

  • GN10290 structure
    GN10290Norcantharidin
    CAS: 29745-04-8
    Purity: >98.00%
  • GN10292 structure
    GN10292Silibinin
    CAS: 22888-70-6
    Purity: >98.00%

    Silibinin est un flavonoïde actif par voie orale, avec des effets hépotoprotecteurs et anticancéreux.

  • GN10293 structure
    GN10293Daidzein
    CAS: 486-66-8
    Purity: >99.50%

    Daidzein is a natural phytoestrogen isoflavone. Daidzein serves as a PPAR activator.

  • GN10298 structure
    GN10298Albiflorin
    CAS: 39011-90-0
    Purity: >98.00%

    Albiflorin, a principal monoterpene glycoside, exhibits strong pharmacological effects in combating inflammation, oxidation and apoptosis.

  • GN10299 structure
    GN10299Vinorelbine
    CAS: 71486-22-1
    Purity: >98.00%

    Vinorelbine est un médicament antimitotique, un dérivé semi-synthétique du paclitaxel, qui exerce son effet antitumoral en inhibant la polymérisation des microtubules dans les cellules tumorales. Vinorelbine est principalement utilisée pour traiter des tumeurs malignes telles que le cancer du poumon non à petites cellules et le cancer du sein métastatique.

  • GN10301 structure
    GN10301Magnolol
    CAS: 528-43-8
    Purity: >99.50%

    Magnolol is a lignan compound extracted from the bark of Magnolia officinalis with multiple pharmacological activities. Magnolol is a dual agonist of RXRα (EC 50 =10.4µM) and PPARγ (EC 50 =17.7µM).

  • GN10302 structure
    GN10302Hypericin
    CAS: 548-04-9
    Purity: >98.00%
  • GN10304 structure
    GN10304Taxifolin
    CAS: 480-18-2
    Purity: >98.00%

    Taxifolin est un inhibiteur de la tyrosinase et possède une activité inhibitrice significative de la collagénase, sa valeur d'IC50 est 193,3μM.

  • GN10306 structure
    GN10306Folic acid
    CAS: 59-30-3
    Purity: >98.00%
  • GN10307 structure
    GN10307Ginsenoside Re
    CAS: 52286-59-6
    Purity: >99.00%

    Ginsenoside Re est un composé naturel présent dans Panax ginseng, doté de puissantes activités antioxydantes et anti-inflammatoires.

  • GN10308 structure
    GN10308Chlorogenic acid
    CAS: 327-97-9
    Purity: >98.00%

    Chlorogenic acid est un agent neuroprotecteur puissant et possède également les propriétés antivirales, antifongiques, antioxydantes et antitumorales. CGA est également impliqué dans la régulation du métabolisme du glucose et des lipides ainsi que dans l'amélioration de la sensibilité à l'insuline.

  • GN10311 structure
    GN10311N－Methylcytisine
    CAS: 486-86-2
    Purity: >99.50%
  • GN10312 structure
    GN10312Polygalasaponin F
    CAS: 882664-74-6
    Purity: >98.00%
  • GN10313 structure
    GN10313Schisantherin B
    CAS: 58546-55-7
    Purity: >99.50%
  • GN10314 structure
    GN10314Picroside I
    CAS: 27409-30-9
    Purity: >99.00%
  • GN10317 structure
    GN103171-Deoxynojirimycin
    CAS: 19130-96-2
    Purity: >98.00%

    1-Deoxynojirimycin est un composé alcaloïde présent dans les feuilles de mûrier et d'autres plantes. Au moyen d'inhiber α-glucosidase et de moduler diverses voies de signalisation.

  • GN10318 structure
    GN10318Danshensu
    CAS: 22681-72-7
    Purity: >98.00%
  • GN10321 structure
    GN10321Glycitein
    CAS: 40957-83-3
    Purity: >98.00%
  • GN10322 structure
    GN10322Pseudolaric Acid C
    CAS: 82601-41-0
    Purity: >99.50%
  • GN10325 structure
    GN10325Nobiletin
    CAS: 478-01-3
    Purity: >99.00%

    Nobiletin est une flavone polyméthoxylée extraite de plantes du genre Citrus. Nobiletin présente divers effets pharmacologiques, notamment des propriétés antioxydantes, anti-inflammatoires et antitumorales.

  • GN10327 structure
    GN10327Chrysophanol
    CAS: 481-74-3
    Purity: >99.50%